Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Hugeltox vs Botox in Essential Blepharospasm
NCT01791881Phase 3Completed
- Sponsor
- Hugel
- Start
- Apr 2008
- Primary completion
- May 2009
- Modality
- Therapeutic Enzymes
- Countries
- 1
01
Overview
A Phase 3 trial of letibotulinumtoxinA in benign essential blepharospasm (BEB), sponsored by Hugel. Started Apr 2008; status: completed.
02
Drugs
letibotulinumtoxinA
03
Conditions
benign essential blepharospasm (BEB)
Beyond the preview
Go deeper on NCT01791881.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01791881.